NTV Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$329K Sell
8,952
-300
-3% -$14.2K 0.04% 246
2025
Q4
$471K Hold
9,252
0.05% 211
2025
Q3
$513K Buy
9,252
+46
+0.5% +$2.69K 0.06% 202
2025
Q2
$635K Sell
9,206
-748
-8% -$50.9K 0.08% 169
2025
Q1
$691K Buy
9,954
+748
+8% +$61.8K 0.09% 158
2024
Q4
$792K Buy
9,206
+256
+3% +$27.7K 0.1% 136
2024
Q3
$1.07M Hold
8,950
0.14% 119
2024
Q2
$1.28M Hold
8,950
0.18% 98
2024
Q1
$1.15M Buy
8,950
+1,650
+23% +$196K 0.18% 106
2023
Q4
$755K Sell
7,300
-200
-3% -$19.8K 0.13% 130
2023
Q3
$682K Hold
7,500
0.12% 131
2023
Q2
$607K Sell
7,500
-300
-4% -$24.5K 0.11% 141
2023
Q1
$621K Hold
7,800
0.12% 133
2022
Q4
$528K Hold
7,800
0.1% 141
2022
Q3
$389K Hold
7,800
0.08% 158
2022
Q2
$435K Hold
7,800
0.09% 159
2022
Q1
$433K Hold
7,800
0.07% 174
2021
Q4
$437K Sell
7,800
-600
-7% -$32.5K 0.07% 168
2021
Q3
$403K Hold
8,400
0.07% 171
2021
Q2
$352K Hold
8,400
0.06% 182
2021
Q1
$283K Hold
8,400
0.05% 196
2020
Q4
$293K Hold
8,400
0.06% 171
2020
Q3
$292K Hold
8,400
0.07% 160
2020
Q2
$275K Hold
8,400
0.07% 157
2020
Q1
$253K Sell
8,400
-400
-5% -$11.9K 0.08% 150
2019
Q4
$255K Hold
8,800
0.07% 156
2019
Q3
$227K Sell
8,800
-400
-4% -$10.1K 0.06% 161
2019
Q2
$235K Hold
9,200
0.07% 163
2019
Q1
$241K Hold
9,200
0.07% 165
2018
Q4
$212K Hold
9,200
0.07% 165
2018
Q3
$217K Sell
9,200
-1,200
-12% -$29.3K 0.06% 177
2018
Q2
$240K Hold
10,400
0.07% 165
2018
Q1
$256K Hold
10,400
0.07% 165
2017
Q4
$279K Sell
10,400
-200
-2% -$5.09K 0.08% 156
2017
Q3
$255K Sell
10,600
-1,400
-12% -$31.6K 0.07% 160
2017
Q2
$257K Sell
12,000
-2,000
-14% -$40.4K 0.08% 159
2017
Q1
$239K Sell
14,000
-800
-5% -$13.9K 0.08% 154
2016
Q4
$265K Sell
14,800
-8,200
-36% -$149K 0.09% 144
2016
Q3
$478K Buy
23,000
+1,000
+5% +$24.8K 0.17% 122
2016
Q2
$591K Buy
22,000
+400
+2% +$11K 0.22% 105
2016
Q1
$585K Sell
21,600
-1,000
-4% -$26.8K 0.22% 106
2015
Q4
$656K Hold
22,600
0.26% 100
2015
Q3
$612K Sell
22,600
-1,000
-4% -$28.3K 0.2% 123
2015
Q2
$646K Buy
23,600
+3,600
+18% +$101K 0.19% 130
2015
Q1
$533K Buy
+20,000
New +$461K 0.16% 138

Other funds holding NVO

NTV Asset Management's NVO Position: Q1 2026 in Review

NTV Asset Management reduced its Novo Nordisk (NVO) stake by 3.2% in Q1 2026, selling an estimated $14.2K and leaving 8,952 shares worth $329K. The position accounts for 0.04% of the portfolio, ranked #246.

NTV Asset Management first reported a position in NVO in Q1 2015 and has held it in 45 quarters since. The position peaked at $1.28M in Q2 2024. 1,273 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

  • NTV Asset Management held 8,952 shares of Novo Nordisk worth $329K as of Q1 2026.
  • NTV Asset Management sold 300 Novo Nordisk shares in Q1 2026, an estimated $14.2K.
  • Novo Nordisk made up 0.04% of NTV Asset Management's portfolio in Q1 2026, its #246 holding.
  • NTV Asset Management first reported a position in Novo Nordisk in Q1 2015 and has held it in 45 quarters since.
  • NTV Asset Management's Novo Nordisk position peaked at $1.28M in Q2 2024.
  • 1,273 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on NTV Asset Management's 13F filing for Q1 2026, filed 28 Apr 2026.